Cargando…
Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
[Image: see text] Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682607/ https://www.ncbi.nlm.nih.gov/pubmed/29028171 http://dx.doi.org/10.1021/acs.jmedchem.7b01221 |
_version_ | 1783278128256253952 |
---|---|
author | Krüger, Dennis M. Glas, Adrian Bier, David Pospiech, Nicole Wallraven, Kerstin Dietrich, Laura Ottmann, Christian Koch, Oliver Hennig, Sven Grossmann, Tom N. |
author_facet | Krüger, Dennis M. Glas, Adrian Bier, David Pospiech, Nicole Wallraven, Kerstin Dietrich, Laura Ottmann, Christian Koch, Oliver Hennig, Sven Grossmann, Tom N. |
author_sort | Krüger, Dennis M. |
collection | PubMed |
description | [Image: see text] Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts. |
format | Online Article Text |
id | pubmed-5682607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-56826072017-11-15 Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions Krüger, Dennis M. Glas, Adrian Bier, David Pospiech, Nicole Wallraven, Kerstin Dietrich, Laura Ottmann, Christian Koch, Oliver Hennig, Sven Grossmann, Tom N. J Med Chem [Image: see text] Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts. American Chemical Society 2017-10-13 2017-11-09 /pmc/articles/PMC5682607/ /pubmed/29028171 http://dx.doi.org/10.1021/acs.jmedchem.7b01221 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
spellingShingle | Krüger, Dennis M. Glas, Adrian Bier, David Pospiech, Nicole Wallraven, Kerstin Dietrich, Laura Ottmann, Christian Koch, Oliver Hennig, Sven Grossmann, Tom N. Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions |
title | Structure-Based
Design of Non-natural Macrocyclic
Peptides That Inhibit Protein–Protein Interactions |
title_full | Structure-Based
Design of Non-natural Macrocyclic
Peptides That Inhibit Protein–Protein Interactions |
title_fullStr | Structure-Based
Design of Non-natural Macrocyclic
Peptides That Inhibit Protein–Protein Interactions |
title_full_unstemmed | Structure-Based
Design of Non-natural Macrocyclic
Peptides That Inhibit Protein–Protein Interactions |
title_short | Structure-Based
Design of Non-natural Macrocyclic
Peptides That Inhibit Protein–Protein Interactions |
title_sort | structure-based
design of non-natural macrocyclic
peptides that inhibit protein–protein interactions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682607/ https://www.ncbi.nlm.nih.gov/pubmed/29028171 http://dx.doi.org/10.1021/acs.jmedchem.7b01221 |
work_keys_str_mv | AT krugerdennism structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT glasadrian structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT bierdavid structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT pospiechnicole structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT wallravenkerstin structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT dietrichlaura structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT ottmannchristian structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT kocholiver structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT hennigsven structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions AT grossmanntomn structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions |